phaseiiThe EURO-CHOLANGIO-NET Cost Action CA18122, the European Cholangiocarcinoma Network (ENSCCA) and The International Cholangiocarcinoma Research Network (ICRN) join forces to support the career development of junior scientists in the field of liver diseases.
We are proud to announce a new mentorship lecture entitled:
“OF DRUGS AND GENES – AN EXCITING JOURNEY IN ACADEMIA, INDUSTRY AND BACK”
planned for:
JULY 6th 2023 at 3.00 pm CET – 9.00 am EST
Our guest speaker will be
VINCENT MOOSER
in conversation with
Paula Olaizola and Ravi Jagatia – EURO-CHOLANGIO-NET YI group members
To register for the seminar, click HERE.
BIOGRAPHY
Vincent Mooser is a physician scientist. He holds since 2019 the Canada Excellence Research Chair in Genomic Medicine at McGill University in Montreal QC. His 40-year career has been driven by his passion for pharmacology and genetics. More specifically the question which has served as his compass has been: how can human genetics support the discovery and development of new therapeutics?
Originally, in parallel to getting his board certification in internal medicine, he gained a comprehensive, 7-year research training in clinical pharmacology, in experimental pharmacology and in human genetics in Switzerland, Australia and in the USA, resp. He then used this training to run his own lab for 6 years in Switzerland. He was then hired by GlaxoSmithKline in Philadelphia PA to lead the effort in genetics for cardiovascular diseases. During his 10-year employment at GSK, he took roles of increasing responsibility, up to vice-president in charge of applied genetics across the company. He returned to Academia in 2011 where he has been building and running large precision medicine projects in Switzerland, then Canada. During his mentorship lecture, he will share his single question-driven, unusual, yet very enjoyable journey in biomedical research and the clinic, at the interface between academia and industry.